Q4 2024 · 13F-HR
REGENERON PHARMACEUTICALS, INC. (REGN)holdings as filed
Filed 2025-02-07 · accession 0001104659-25-010583
$1.09B
Reported value
6
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02043Q107 | ALNY | Alnylam Pharmaceuticals, Inc. | $1.05B | 95.5% | 4,444,445 | Common | SOLE |
| 45826J105 | NTLA | Intellia Therapeutics, Inc. | $43.2M | 3.94% | 3,702,995 | Common | SOLE |
| 901384107 | TSVT* | 2seventy bio, Inc. | $3.7M | 0.34% | 1,254,827 | Common | SOLE |
| 007002108 | TORCEUR | Adicet Bio, Inc. | $931,392 | 0.09% | 968,183 | Common | SOLE |
| 00773U207 | AVU0 | Adverum Biotechnologies, Inc. | $844,845 | 0.08% | 180,909 | Common | SOLE |
| 09609G209 | BLE0 | bluebird bio, Inc. | $175,140 | 0.02% | 21,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.